Provided By GlobeNewswire
Last update: Aug 14, 2025
WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), today issued the following statement from Ryan Saadi, M.D., M.P.H., Founder and CEO.
Read more at globenewswire.com0.9364
+0.03 (+3.54%)
NASDAQ:TVGNW (8/22/2025, 8:00:02 PM)
0.0601
0 (0%)
Find more stocks in the Stock Screener